Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 14, 2022

SELL
$12.79 - $26.88 $158,493 - $333,096
-12,392 Closed
0 $0
Q3 2021

Oct 20, 2021

BUY
$26.67 - $38.76 $91,158 - $132,481
3,418 Added 38.09%
12,392 $345,000
Q2 2021

Jul 23, 2021

BUY
$23.94 - $36.68 $981 - $1,503
41 Added 0.46%
8,974 $284,000
Q1 2021

Apr 14, 2021

SELL
$31.33 - $59.61 $50,911 - $96,866
-1,625 Reduced 15.39%
8,933 $294,000
Q4 2020

Jan 14, 2021

SELL
$27.03 - $75.62 $3,676 - $10,284
-136 Reduced 1.27%
10,558 $649,000
Q3 2020

Oct 13, 2020

BUY
$23.52 - $47.9 $251,522 - $512,242
10,694 New
10,694 $321,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $145M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.